Show simple item record

dc.contributor.authorEseberri Barace, Itziar ORCID
dc.contributor.authorTrepiana Arin, Jenifer ORCID
dc.contributor.authorLéniz Rodríguez, Asier
dc.contributor.authorGómez García, Iker ORCID
dc.contributor.authorCarr Ugarte, Helen
dc.contributor.authorGonzález, Marcela
dc.contributor.authorPortillo Baquedano, María Puy ORCID
dc.date.accessioned2022-05-19T11:20:51Z
dc.date.available2022-05-19T11:20:51Z
dc.date.issued2022-05-04
dc.identifier.citationNutrients 14(9) : (2022) // Article ID 1925es_ES
dc.identifier.issn2072-6643
dc.identifier.urihttp://hdl.handle.net/10810/56616
dc.description.abstractWhen analysing the beneficial effects of phenolic compounds, several factors that exert a clear influence should be taken into account. The content of phenolic compounds in foods is highly variable, directly affecting individual dietary intake. Once ingested, these compounds have a greater or lesser bioaccessibility, defined as the amount available for absorption in the intestine after digestion, and a certain bioavailability, defined as the proportion of the molecule that is available after digestion, absorption and metabolism. Among the external factors that modify the content of phenolic compounds in food are the variety, the cultivation technique and the climate. Regarding functional foods, it is important to take into account the role of the selected food matrix, such as dairy matrices, liquid or solid matrices. It is also essential to consider the interactions between phenolic compounds as well as the interplay that occurs between these and several other components of the diet (macro- and micronutrients) at absorption, metabolism and mechanism of action levels. Furthermore, there is a great inter-individual variability in terms of phase II metabolism of these compounds, composition of the microbiota, and metabolic state or metabotype to which the subject belongs. All these factors introduce variability in the responses observed after ingestion of foods or nutraceuticals containing phenolic compounds.es_ES
dc.description.sponsorshipThis study was supported by Instituto de Salud Carlos III (CIBERobn) under Grant CB12/03/30007.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.subjectphenolic compoundses_ES
dc.subjectbioaccesibilityes_ES
dc.subjectbioavailabilityes_ES
dc.subjectmetabotypees_ES
dc.subjectchronobiologyes_ES
dc.titleVariability in the Beneficial Effects of Phenolic Compounds: A Reviewes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2022-05-12T19:36:20Z
dc.rights.holder2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/2072-6643/14/9/1925/htmes_ES
dc.identifier.doi10.3390/nu14091925
dc.departamentoesFarmacia y ciencias de los alimentos
dc.departamentoeuFarmazia eta elikagaien zientziak


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).